Analysis of prognostic factors of nasopharyngeal carcinoma: Impact of in situ hybridization for Epstein-Barr virus encoded small RNA 1

被引:20
作者
Nakao, K
Mochiki, M
Nibu, K
Sugasawa, M
Uozaki, H
机构
[1] Univ Tokyo, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1138655, Japan
[3] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, Japan
关键词
D O I
10.1016/j.otohns.2005.11.022
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 [耳鼻咽喉科学];
摘要
OBJECTIVES: To evaluate the impact of clinical, histopathological, and molecular biological parameters on the prognosis of nasopharyngeal carcinoma (NPC). STUDY DESIGN AND SETTING: The clinical records of 48 patients with a diagnosis of NPC were retrospectively reviewed. In situ hybridization for Epstein-Barr virus encoded small RNA I (EBER-ISH) was applied for 30 paraffin-embedded specimens available. Prognostic factors of NPC were meticulously analyzed. RESULTS: The EBER-ISH signal was shown to be highly significant as a favorable prognostic factor (P = 0.007). Although EBV was more commonly associated with Type III NPC, EBERISH-positive Type I-II NPC had also significantly better survival rate than EBER-ISH-negative Type I-II NPC (P = 0.036). CONCLUSIONS: In addition to the WHO histopathological grade, the 1997 UICC staging, nodal status, and distant metastasis at presentation, the EBER-ISH signal was shown to be significant as a prognostic factor. SIGNIFICANCE: This is the first report to describe the EBERISH as an independent prognostic factor of NPC regardless of histopathology.
引用
收藏
页码:639 / 645
页数:7
相关论文
共 24 条
[1]
BROUSSET P, 1992, LAB INVEST, V67, P457
[2]
Burgos JS, 2001, ANTICANCER RES, V21, P3921
[3]
EXPRESSION OF EPSTEIN-BARR VIRUS-ENCODED PROTEINS IN NASOPHARYNGEAL CARCINOMA [J].
FAHRAEUS, R ;
FU, HL ;
ERNBERG, I ;
FINKE, J ;
ROWE, M ;
KLEIN, G ;
FALK, K ;
NILSSON, E ;
YADAV, M ;
BUSSON, P ;
TURSZ, T ;
KALLIN, B .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (03) :329-338
[4]
DETECTION OF EPSTEIN-BARR-VIRUS SMALL RNAS IN ROUTINE PARAFFIN SECTIONS USING NONISOTOPIC RNA/RNA IN-SITU HYBRIDIZATION [J].
HAMILTONDUTOIT, SJ ;
PALLESEN, G .
HISTOPATHOLOGY, 1994, 25 (02) :101-111
[5]
EPSTEIN-BARR VIRUS-SPECIFIC IGA SERUM ANTIBODIES AS AN OUTSTANDING FEATURE OF NASOPHARYNGEAL CARCINOMA [J].
HENLE, G ;
HENLE, W .
INTERNATIONAL JOURNAL OF CANCER, 1976, 17 (01) :1-7
[6]
Epstein-Barr virus-associated carcinomas: facts and fiction [J].
Herrmann, K ;
Niedobitek, G .
JOURNAL OF PATHOLOGY, 2003, 199 (02) :140-145
[7]
Hwang TZ, 1998, ANTICANCER RES, V18, P4581
[8]
Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma [J].
Nakao, K ;
Yuge, T ;
Mochiki, M ;
Nibu, K ;
Sugasawa, M .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (03) :338-340
[9]
P53 OVEREXPRESSION AND EPSTEIN-BARR-VIRUS INFECTION IN UNDIFFERENTIATED AND SQUAMOUS-CELL NASOPHARYNGEAL CARCINOMAS [J].
NIEDOBITEK, G ;
AGATHANGGELOU, A ;
BARBER, P ;
SMALLMAN, LA ;
JONES, EL ;
YOUNG, LS .
JOURNAL OF PATHOLOGY, 1993, 170 (04) :457-461
[10]
EPSTEIN-BARR-VIRUS AND CARCINOMAS - UNDIFFERENTIATED CARCINOMAS BUT NOT SQUAMOUS-CELL CARCINOMAS OF THE NASOPHARYNX ARE REGULARLY ASSOCIATED WITH THE VIRUS [J].
NIEDOBITEK, G ;
HANSMANN, ML ;
HERBST, H ;
YOUNG, LS ;
DIENEMANN, D ;
HARTMANN, CA ;
FINN, T ;
PITTEROFF, S ;
WELT, A ;
ANAGNOSTOPOULOS, I ;
FRIEDRICH, R ;
LOBECK, H ;
SAM, CK ;
ARAUJO, I ;
RICKINSON, AB ;
STEIN, H .
JOURNAL OF PATHOLOGY, 1991, 165 (01) :17-24